Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study-Reference-Cited by-同舟云学术

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study

Published:2020-07-01 Issue:3 Volume:84 Page:323-330
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Yager Jenna,Castillo-Mancilla Jose,Ibrahim Mustafa E.,Brooks Kristina M.,McHugh Cricket,Morrow Mary,McCallister Scott,Bushman Lane R.,MaWhinney Samantha,Kiser Jennifer J.,Anderson Peter L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference35 articles.

1. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med.,2012

2. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med.,2010

3. Tenofovir-based preexposure prophylaxis for HIV infection among African women;Marrazzo;N Engl J Med.,2015

4. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;N Engl J Med.,2012

5. Preexposure prophylaxis for HIV infection among African women;Van Damme;N Engl J Med.,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial;The Lancet HIV;2024-08

2. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women;New England Journal of Medicine;2024-07-24

3. A Pilot Randomized Controlled Trial of an mHealth Intervention to Improve PrEP Adherence Among Young Sexual Minority Men;AIDS and Behavior;2024-05-31

4. Cumulative Tenofovir Exposure Among Patients With Human Immunodeficiency Virus/Hepatitis B Coinfection With Differential Viral Suppression;Clinical Infectious Diseases;2024-05-03

5. Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons With Human Immunodeficiency Virus Receiving Tenofovir Alafenamide and Emtricitabine–Based Antiretroviral Therapy (QUANTI-TAF);Clinical Infectious Diseases;2024-04-18